⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMGN News
Amgen Inc
FDA Approves Amgen’s UPLIZNA® (inebilizumab-cdon) for Generalized Myasthenia Gravis (gMG), Expanding Treatment Options for Patients Living with Autoimmune Neuromuscular Disease
globenewswire.com
AMGN
CGTN: How does China set tone for economic work in 2026? USA - English USA - English Korea - 한국어
prnewswire.com
BABA
JD
NTES
PDD
BIDU
XPEV
NIO
LI
BYD
AMC
CMG
MCD
SBUX
YUM
COKE
PEP
KHC
MDLZ
COST
WMT
AMZN
GOOG
MSFT
NVDA
INTC
AMD
QCOM
TSM
MU
AAPL
MS
JPM
GS
BAC
WFC
C
V
MA
AXP
BBY
HD
LOW
TJX
ROST
ULTA
LULU
NKE
UA
PVH
RL
HOG
GM
F
STLA
TM
HON
GE
CAT
DE
IBM
ORCL
SAP
CRM
ADBE
NFLX
DIS
CMCSA
VZ
T
TMUS
CHTR
SIRI
PFE
JNJ
MRK
ABBV
BMY
GILD
AMGN
LLY
BIIB
REGN
VRTX
XOM
CVX
SHEL
TTE
COP
MPC
VLO
ET
KMI
NEE
DUK
SO
EXC
AEP
SRE
PCG
ED
XEL
WEC
EIX
D
PNW
CMS
CEG
NRG
ECL
LIN
APD
DD
DOW
MMM
BA
LMT
RTX
GD
NOC
AVGO
TXN
ADI
NXPI
MRVL
ON
MCHP
ALGN
ISRG
MDT
SYK
ZBH
BAX
EW
TFX
AZN
BNTX
CRSP
EDIT
NTLA
CPRT
AZO
ORLY
LAD
CAR
AVTR
ILMN
DXCM
GOOGL
META
FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
prnewswire.com
AMGN
Fusion Proteins Market to Hit $64.9 Billion by 2030
globenewswire.com
AMGN
BMY
PFE
MRK
Prolynx Secures $70 Million Series A to Advance Portfolio of Ultra-Long-Acting Obesity Candidates and Appoints Chris Boulton as Chief Executive Officer
globenewswire.com
AMGN
SNY
AZN
Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
TAK
AMGN
JNJ
BMY
Milken Institute Partners with Digital Agency, Velir x Brooklyn Data, to Launch First-of-Its-Kind Women's Health Network Digital Platform
prnewswire.com
AMGN
MRK
MSFT
GEHC
DAR
Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
globenewswire.com
GSK
Z
AMGN
BMY
ABT
AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND
prnewswire.com
AMGN
Global Medical Device Contract Manufacturing Market is Predicted to Cross the USD 190 Billion Mark by 2032, Owing to the Rising Demand for Advanced Healthcare Solutions | DelveInsight
globenewswire.com
TMO
PFE
AMGN
BMY
MRK
DHR
ABBV
GOOG
MSFT
JNJ
MDT
BSX
SYK
EW
ISRG
EMR
BIOX
EXAS
QRVO
TER
ADI
TXN
ON
INTC
NVDA
AMD
HPQ
DELL
IBM
GE
FISV
ADP
PAYX
NOW
CRM
ORCL
SAP
ADSK
CDNS
SNPS
AMAT
INFY
HPE
LOGI
ATHM
BIIB
GILD
REGN
VRTX
AMRN
AZN
LLY
NVS
CRSP
EDIT
NTLA
ALNY
INCY
XRAY
COO
MASI
IRTC
MRNA
EMB
ADMA
ICUI
HOLX
LH
DGX
RDNT
EVTC
AFYA
CHKP
DDOG
SMCI
ALGN
THRY
PTC
MCHP
NXPI
QCOM
SWKS
MU
WDC
STX